Abstract

We developed a fully automated method for brain tumor segmentation using deep learning; 285 brain tumor cases with multiparametric magnetic resonance images from the BraTS2018 data set were used. We designed 3 separate 3D-Dense-UNets to simplify the complex multiclass segmentation problem into individual binary-segmentation problems for each subcomponent. We implemented a 3-fold cross-validation to generalize the network's performance. The mean cross-validation Dice-scores for whole tumor (WT), tumor core (TC), and enhancing tumor (ET) segmentations were 0.92, 0.84, and 0.80, respectively. We then retrained the individual binary-segmentation networks using 265 of the 285 cases, with 20 cases held-out for testing. We also tested the network on 46 cases from the BraTS2017 validation data set, 66 cases from the BraTS2018 validation data set, and 52 cases from an independent clinical data set. The average Dice-scores for WT, TC, and ET were 0.90, 0.84, and 0.80, respectively, on the 20 held-out testing cases. The average Dice-scores for WT, TC, and ET on the BraTS2017 validation data set, the BraTS2018 validation data set, and the clinical data set were as follows: 0.90, 0.80, and 0.78; 0.90, 0.82, and 0.80; and 0.85, 0.80, and 0.77, respectively. A fully automated deep learning method was developed to segment brain tumors into their subcomponents, which achieved high prediction accuracy on the BraTS data set and on the independent clinical data set. This method is promising for implementation into a clinical workflow.

Highlights

  • Gliomas are the most common primary brain malignancy and represent a heterogeneous set of tumors

  • The BraTS2018 data set consisted of a total of 285 subjects: 210 subjects with high-grade glioma (HGG) and 75 subjects with low-grade glioma (LGG) [4, 5]

  • Average Dice-scores for the 3-fold cross validation using 75% overlapping patches were 0.90, 0.82, and 0.79 for whole tumor (WT), tumor core (TC), and enhancing tumor (ET), respectively

Read more

Summary

Introduction

Gliomas are the most common primary brain malignancy and represent a heterogeneous set of tumors. Glioma segmentation based on magnetic resonance imaging (MRI) can be useful in predicting aggressiveness and response to therapy. MRI segmentation of gliomas is largely based on imaging correlates of histopathological findings. Gliomas are generally segmented into active tumor, necrotic tissue, and surrounding edema (ED) based on conventional MRI sequences. Multiple MRI sequences that generate variable tissue contrast are simultaneously used for glioma segmentation [1]. Manual tumor segmentation is a tedious, time-intensive task that requires a human expert to delineate components. Manual tumor segmentation is often fraught with intra-rater and inter-rater variability, resulting in imprecise boundary demarcation [2, 3]. An intra-rater variability of 20% and an inter-rater variability of 28% has been reported for manual segmentation of brain tumors [4, 5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call